Jafron Biomedical Co.,Ltd. Financials

Market Capitalization CN¥16.16 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	30.26
Forward PE	11.71
Price to Sales TTM	CN¥7.71
Price to Book MRQ	CN¥4.44
Enterprise to Revenue	6.96
Enterprise to EBITDA	19.24

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	23.64%
Operating Margin	26.74%
Return on Assets TTM	6.64%
Return on Equity TTM	14.20%

Income Statement

Revenue TTM	CN¥2,037,652,480
Revenue per Share TTM	CN¥2.69
Quarterly Revenue Growth	-39.80%
Gross Profit TTM	CN¥1,610,156,416
EBITDA	CN¥858,168,788
Net Income to Common TTM	CN¥481,791,488
Diluted EPS TTM	CN¥0.65
Quarterly Earnings Growth YoY	-73.40%

Balance Sheet

Total Cash MRQ	CN¥2,486,807,040
Total Cash per Share MRQ	CN¥3.21
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	41.75
Current Ratio MRQ	4.26
Book Value per Share MRQ	CN¥4.43

Cash Flow

Operating Cash Flow TTM	CN¥752,623,744
Levered Free Cash Flow TTM	CN¥381,846,496

300529 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	798,605,275
Float Shares	379,863,509
Avg 10 Volume	3,107,110
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	51.05%
% Held by Institutions	7.44%

Stock Price Summary

Beta	0.49
Fifty Two Week Low	CN¥19.19
Fifty Two Week High	CN¥30.12
Fifty Two Week Change	-45.91%
Day 50 MA	CN¥20.28
Day 200 MA	CN¥22.12

Dividends and Splits

Forward Annual Dividend Rate	CN¥3.20
Forward Annual Dividend Yield	16.27%
Trailing Annual Dividend Rate	CN¥0.80
Trailing Annual Dividend Yield	4.07%
Payout Ratio	123.08%
Dividend Date
Ex Dividend Date	2025-05-26
Last Split Factor
Last Split Date	2020-05-20